Published in Acta Anaesthesiol Scand on February 01, 1987
Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations. ScientificWorldJournal (2013) 0.82
Oxidative capacity and fatigability in run-trained malignant hyperthermia-susceptible mice. Muscle Nerve (2012) 0.78
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol (1994) 8.37
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
Isolation of Escherichia coli serotype O157:H7 and other Shiga-like-toxin-producing E. coli from dairy cattle. J Clin Microbiol (1991) 4.69
Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry (1998) 3.78
Access to coronary catheterisation: fair shares for all? BMJ (1993) 3.45
A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology (1994) 3.23
The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis (2001) 3.14
Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS (1999) 3.01
Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Infect Immun (1988) 2.99
Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr (2001) 2.80
Clinical course and prognosis of temporal lobe epilepsy. A survey of 666 patients. Brain (1971) 2.53
Increased recovery of psychrophilic bacteria by the use of a new medium with lower solidifying temperature. Appl Microbiol (1968) 2.40
The incidence of the non-metastatic neurological syndromes of obscure origin in the reticuloses. Brain (1970) 2.39
Muscular dystrophy: evidence for a neural factor. Nature (1970) 2.12
Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth (1971) 2.06
The nutritional status of vegans and vegetarians. Proc Nutr Soc (1967) 2.03
Pyrophosphate:fructose 6-phosphate 1-phosphotransferase and glycolysis in non-photosynthetic tissues of higher plants. Biochem J (1985) 2.02
The tumour-suppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge. Oncogene (2006) 1.88
Neurological syndromes in the reticuloses. Brain (1971) 1.87
Evidence for related myopathies in exertional heat stroke and malignant hyperthermia. Lancet (1991) 1.77
Malignant hyperpyrexia myopathy. Q J Med (1973) 1.73
A survey of the use of vitamin B12 in general practice. Practitioner (1970) 1.70
Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility. Br J Anaesth (1992) 1.69
The measurement of food and energy intake in man-an evaluation of some techniques. Am J Clin Nutr (1980) 1.68
H and M antigens of Histoplasma capsulatum: preparation of antisera and location of these antigens in yeast-phase cells. Infect Immun (1976) 1.65
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
Estimation of the correct length of tracheal tubes in adults. Anaesthesia (1993) 1.53
Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry (1969) 1.49
Masseteric muscle spasm as a normal response to suxamethonium. Br J Anaesth (1990) 1.49
Experimental myositis: the in-vivo and in-vitro activity of lymph-node cells. J Pathol (1971) 1.47
Increased contractility and calcium sensitivity in cardiac myocytes isolated from endurance trained rats. Cardiovasc Res (2001) 1.46
Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus. Gastroenterology (1979) 1.42
An electrophysiological study of Duchenne dystrophy. J Neurol Neurosurg Psychiatry (1971) 1.41
Veganism, clinical findings and investigations. Am J Clin Nutr (1970) 1.40
Manipulation of substrate utilization with somatostatin in patients with secondary multiple organ dysfunction syndrome. Crit Care Med (1995) 1.40
Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth (2010) 1.39
Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia? Br J Anaesth (1992) 1.36
Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II. J Clin Microbiol (1989) 1.35
Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med (1971) 1.35
Stability of fluorescent antibody conjugates stored under various conditions. J Clin Microbiol (1976) 1.33
Studies upon the relationship between baroreceptor and sympathetic activity. Q J Exp Physiol Cogn Med Sci (1968) 1.32
Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet (1994) 1.32
Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder. Br J Dermatol (1971) 1.30
Lymphocyte transformation in the Guillain-Barré syndrome. Lancet (1969) 1.29
Screening for malignant hyperpyrexia. Br Med J (1972) 1.27
Back pain in childhood. Spine (Phila Pa 1976) (1989) 1.27
The effect of a strict vegetarian diet on the faecal flora and faecal steroid concentration. J Pathol (1971) 1.24
Familial oculomotor palsy with Bell's palsy. Brain (1970) 1.21
Malignant hyperpyrexia induced by nitrous oxide and treated with dexamethasone. Br Med J (1974) 1.21
Role and location of NAD malic enzyme in thermogenic tissues of Araceae. Arch Biochem Biophys (1983) 1.20
Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child (1992) 1.19
Genetic variation in RYR1 and malignant hyperthermia phenotypes. Br J Anaesth (2009) 1.18
Motoneurone dysfunction in patients with hemiplegic atrophy. Nat New Biol (1971) 1.17
Cardiovascular and haematological responses of Atlantic cod (Gadus morhua) to acute temperature increase. J Exp Biol (2006) 1.16
Comparison of propofol and thiopentone for laryngeal mask insertion. Anaesthesia (1991) 1.15
Meat grinders and molecular epidemiology: two supermarket outbreaks of Escherichia coli O157:H7 infection. J Infect Dis (1996) 1.15
Destruction of muscle cultures by lymphocytes from cases of polymyositis. Acta Neuropathol (1970) 1.14
Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci (Lond) (1993) 1.14
Socioeconomic circumstances and the risk of bowel cancer in Northern Ireland. J Epidemiol Community Health (1996) 1.12
Invalidity of hand heating as a method to arterialize venous blood. Clin Chem (1990) 1.12
Methodological considerations in arterialization of venous blood. Clin Chem (1991) 1.10
Studies of vegans: the fatty acid composition of plasma choline phosphoglycerides, erythrocytes, adipose tissue, and breast milk, and some indicators of susceptibility to ischemic heart disease in vegans and omnivore controls. Am J Clin Nutr (1978) 1.09
Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat (2004) 1.09
Cerebral localisation in articulatory dyspraxia. J Neurol Neurosurg Psychiatry (1992) 1.07
Hypoglycaemia, hypothermia and shivering in man. Clin Sci (Lond) (1981) 1.06
Paying the piper--calling the tune? Anaesthesia (1994) 1.06
Sensitized lymphocytes in muscular dystrophy: evidence for a neural factor in pathogenesis. J Neurol Neurosurg Psychiatry (1971) 1.05
Concurrence of multiple sclerosis and glioma. J Neurol Neurosurg Psychiatry (1974) 1.05
Malignant hyperpyrexia. Br J Hosp Med (1980) 1.05
Preparation of agglutinating antisera and fluorescent-antibody conjugates against Pasteurella tularensis in equines. Appl Microbiol (1970) 1.04
Esmolol hydrochloride for management of the cardiovascular stress responses to laryngoscopy and tracheal intubation. Br J Anaesth (1992) 1.04
Preparation of reference antisera for laboratory diagnosis of blastomycosis. J Clin Microbiol (1979) 1.03
Anaesthesia and acute dermatomyositis/polymyositis. Br J Anaesth (1988) 1.02
Evaluation of histoplasmin for the presence of H and M antigens: some difficulties encountered in the production and evaluation of a product suitable for the immunodiffusion test. J Clin Microbiol (1975) 1.00
Which behavior does the lamprey central motor program mediate? Science (1983) 1.00
Hypermetabolism in arthrogryposis multiplex congenita. Anaesthesia (1991) 1.00
Weight loss in chronic obstructive pulmonary disease. Eur Respir J (1993) 1.00
Histopathological and neuropharmacological aspects of malignant hyperpyrexia. Proc R Soc Med (1973) 0.99
S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol (2005) 0.99
The influence of intravenous glucose on body temperature. Q J Exp Physiol (1981) 0.98
Practical limitations of the Deltatrac indirect calorimeter. Clin Nutr (1995) 0.98
Myocardial infarction causes increased expression but decreased activity of the myocardial Na+-Ca2+ exchanger in the rabbit. J Physiol (2003) 0.97
Cloxacillin in treatment of acute osteomyelitis. Br Med J (1967) 0.97
Lymphocyte sensitization to nervous tissues and muscle in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1971) 0.95
Diurnal and seasonal variation in oral glucose tolerance: studies in the Antarctic. Diabetologia (1975) 0.95
HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics (1991) 0.95
Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility. Hum Mol Genet (1993) 0.93
Monitoring preoxygenation. Br J Anaesth (1994) 0.93
Incidence of osteoporosis in vegetarians and omnivores. Am J Clin Nutr (1972) 0.93
Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized. Br J Anaesth (1979) 0.92
Studies of body temperatures, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiol Scand (1983) 0.92